Rambus Is Poised for a Pullback Despite Rising 42% YTD

Photo of Vandita Jadeja
By Vandita Jadeja Published

Quick Read

  • After surging 133% in a year, RMBS earns a SELL rating with a $117.57 price target implying 17% downside from current levels.

  • Rambus's Q1 2026 results show operating margins compressing from 46% to 42%, EPS missing consensus, and royalty revenue declining year over year.

  • The bull case targets $175 on HBM4E design wins inside the AI capex wave, while the bear case lands at $98 on royalty erosion.

  • Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Rambus didn't make the cut. Grab the names FREE today.

Rambus Is Poised for a Pullback Despite Rising 42% YTD

© Thinkstock

After a rally that has lifted Rambus (NASDAQ:RMBS | RMBS Price Prediction) 133.15% over the past year, the memory interface IP leader trades at $141.17. Our 24/7 Wall St. price target for Rambus is $117.57 over the next 12 months, implying 16.72% downside from current levels.

Our recommendation is sell, with high confidence at 90%. The shares are pricing in flawless execution against a backdrop of tightening DRAM supply and compressing margins.

An infographic titled 'Rambus Inc (RMBS) 12-Month Price Prediction' with a prominent 'SELL' recommendation. The call indicates a movement from $141.17 to a target price of $117.57, showing a downside of -16.72% with a High (90%) confidence level. The section 'How We Got There' displays a weighted base of $101.09, derived from Trailing P/E ($141.17, 20% weight), Forward P/E ($58.56, 30% weight), and Analyst Consensus ($145.25, 30% weight). The 'Our Adjustments' waterfall chart illustrates changes from the $101.09 base, showing increases for Sector Momentum (+1.15x multiplier) and Analyst Consensus (+0.047), decreases for Earnings Growth (-0.002) and Volatility (-0.016), and a final increase for +247Factor (+1.163x), arriving at the $117.57 Final Target. The 'What Could Go Right' section, in green, lists drivers like AI/HBM4E & DDR5 ramp with a potential target of $175.08 (+24.02% upside) and an Analyst Consensus of 7 BUY, 0 SELL ratings. The 'What Could Go Wrong' section, in red, highlights risks such as margin squeeze, royalty decline, and high valuation (62x Trailing P/E, 20x P/S) with a potential downside target of $98.18 (-30.45% downside). The 'Bottom Line' reiterates 'SELL -> $117.57 (-16.72%)' and states that valuation and margin pressure outweigh AI potential at current levels.
24/7 Wall St.

24/7 Wall St. Price Target Summary

Metric Value
Current Price $141.17
24/7 Wall St. Price Target $117.57
Upside/Downside -16.72%
Recommendation SELL
Confidence Level 90%

Why We Could Be Wrong

Our 24/7 Wall St. price target of $117.57 sits below where Rambus trades today, and the bull case is real. The HBM4E memory controller IP ramp and the AI inference data center cycle could push product revenue meaningfully above guidance.

Wall Street analysts carry a consensus target of $145.25 with 7 buy ratings and zero sells. Treat our target as one datapoint among many.

A Year-Long Rally Meets a Margin Squeeze

RMBS is up 53.63% year to date and 15.68% over the past month, though it pulled back 2.28% last week and sits 17% from its 52-week high of $174.10.

Q1 2026 revenue of $180.19 million beat slightly, but non-GAAP EPS of $0.63 missed the $0.6363 consensus. Non-GAAP operating margin compressed to 42% from 46%, R&D rose 18%, and royalty revenue declined year over year. An analyst downgrade citing tightening DRAM supply followed the report.

RMBS price target

The Case for $175+

Bulls have catalysts. CEO Luc Seraphin said “The growth of AI inference and agentic workloads in the data center continues to drive demand for higher memory bandwidth, efficient data movement, and scalable connectivity.”

DDR5 RCD leadership, the LPDDR5X SOCAMM2 server module chipset, and the industry-fastest HBM4E memory controller IP position Rambus squarely inside the AI capex wave. Q2 2026 guidance calls for revenue of $186 million to $204 million. Our bull-case 12-month scenario reaches $175.08, a 24.02% gain.

RMBS analyst ratings

The Risks Worth Watching

RMBS trades at 62 trailing earnings and a price-to-sales ratio of 20, leaving little margin for error. Royalty revenue declined to $69.64 million in Q1, the CFO transitioned in Q4 2025, and supply chain disruption was disclosed.

Bulls would counter that R&D spending is the kind of investment that funds the HBM4E and SOCAMM2 ramps, and the balance sheet shows $1.39 billion in equity. Still, our bear case lands at $98.18, a 30.45% decline.

RMBS price scenario

Rambus Price Prediction 2026-2030

The 24/7 Wall St. price target of $117.57 reflects a sell call at 90% confidence. The tipping factor is valuation: a forward multiple of 24 is reasonable, but the stock trades far above that anchor.

The bull thesis strengthens if HBM4E design wins translate into a step-function ramp in product revenue. The bear thesis strengthens if royalty revenue keeps slipping and margins keep compressing. Today, the setup favors patience.

Year 24/7 Wall St. Price Target
2026 $117.57
2027 $115.00
2028 $110.50
2029 $108.25
2030 $107.71

These projections assume Rambus continues executing its current DDR5 and HBM roadmap. Significant upside could result from accelerated HBM4E adoption, while downside risk centers on prolonged DRAM supply tightness and royalty erosion.

Photo of Vandita Jadeja
About the Author Vandita Jadeja →

Vandita Jadeja is a financial copywriter who loves to read and write about stocks. She believes in buying and holding for long term gains. Her knowledge of words and numbers helps her write clear stock analysis. She has contributed to several publications, including the Joy Wallet, Benzinga, The Motley Fool and InvestorPlace.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

SMCI Vol: 94,785,850
GLW Vol: 9,800,750
ON Vol: 6,247,213
ABBV Vol: 4,982,686
SWKS Vol: 3,094,613

Top Losing Stocks

CTRA Vol: 73,319,495
GEN Vol: 3,360,016
VRSN Vol: 806,084
MRNA Vol: 5,759,014
PLTR Vol: 36,397,509